Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now early-phase tilt small index

Microbiome: early-phase trial registry

4 of 13 indexed Microbiome trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,315 of 28,707 conditions by registered trial count.

13 US clinical trials · 4 currently recruiting · #1,315 of 28,707 conditions by registered trial count

Microbiome: 13 US clinical trials tracked, 4 recruiting.

Microbiome is the subject of 13 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Stanford University, running 3 of these trials.

Enrollment posture brief

Registry condition microbiome

OPEN 4 | RECR 31% | LATE 0 | EARLY 2 | RANK #1315 | SPON 3

Nearest open-share peer: Acute Decompensated Heart Failure (31% recruiting · 13 trials)

ACL Injury61.5%Acute Biphenotypic Leukemia46.2%Microbiome (this)31%Accidental Falls30.8%Actinic Keratoses23.1%
Open-enrollment share among volume-matched conditions near Microbiome

Microbiome lists 4 open slots (31% of 13 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Microbiome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Microbiome is recruiting below its size-band peers.

    4 of 13 indexed trials (30.8%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Microbiome research.

    Stanford University accounts for 3 of 13 trials (23.1%). 9 distinct sponsors appear on at least one study for this condition label.

  3. Typical Microbiome enrolment sits around 90 participants.

    Median target enrolment is 90 among the 13 trials that report a genuine target (sentinel values excluded). 7 of those (53.8%) plan for fewer than 100 participants.

  4. Microbiome research is mostly interventional.

    11 interventional and 2 observational studies make up this index (84.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 21

Open and recent trials

13 total, page 1 of 1

RECRUITING 275 participants

The Role of Brain-Bone Marrow-Gut Interaction Following Major Trauma

University of Florida

NCT06606119

RECRUITING NA 250 participants

Flourish: Exploring the Early Infant Gut Microbiome

Seeding

NCT07333482

RECRUITING Phase 2 90 participants

Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV

University of California, San Diego

NCT05514899

RECRUITING Early Phase 1 20 participants

MOdification Of THe Early-Life Respiratory Microbiome Through Vaginal SEEDing

Vanderbilt University Medical Center

NCT05505110

ACTIVE NOT RECRUITING 500 participants

Alterations of the Microbiome During Critical Illness With Short and Long Term Clinical Outcomes

University of Chicago

NCT04552834

ACTIVE NOT RECRUITING NA 135 participants

Maternal & Offspring Microbiome Study

Stanford University

NCT05123612

ACTIVE NOT RECRUITING NA 120 participants

IGNITE Firefighters' Health

Stanford University

NCT06567561

ACTIVE NOT RECRUITING NA 100 participants

Infant Restore: Efficacy of Microbiome Analysis and Education

Seeding

NCT06424691

ACTIVE NOT RECRUITING NA 80 participants

Alcoholic Liver Disease and the Gut Microbiome

University of California, Los Angeles

NCT05007470

COMPLETED NA 38 participants

Investigating the Detection of Bovine and Soy Proteins in Human Milk

University of Idaho

NCT04851340

COMPLETED NA 38 participants

Evaluation of Two Regimens, With Healthy Male and Female Babies, Ages 3-6 Months Old, Using Various Assessments.

Johnson & Johnson Consumer Inc. (J&JCI)

NCT03457857

COMPLETED NA 38 participants

SWAP-MEAT: Study With Appetizing Plant Food - Meat Eating Alternatives Trial

Stanford University

NCT03718988

COMPLETED NA 30 participants

Effect of Strawberry Consumption on the Microbiome

University of California, Los Angeles

NCT04217122

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1

Named interventions

Most-linked intervention names on Microbiome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Consult Call Behavioral
2 trials
Tailored Recommendations Dietary supplement
2 trials
Plant Alternative products Behavioral
1 trials
Meat products Behavioral
1 trials
Cleanser and Lotion Other
1 trials
Cleanser Other
1 trials
Cow's Milk Other
1 trials
placebo powder Other
1 trials

US sites by state

Facility locations filed on Microbiome trials. A trial with sites in several states counts in each.

California 6 trials
Texas 2 trials
Tennessee 1 trials
New Jersey 1 trials
Illinois 1 trials
Idaho 1 trials
Florida 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Microbiome page

13 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Microbiome condition card totals 13 registered trials; most-linked intervention Consult Call; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.